Background <p>For survival studies, pooling hazard ratios (HRs) across multiple clinical trials through meta-analysis is commonly performed to achieve widely accepted and robust conclusions. However, clinical trials sometimes do not report HRs.</p> Methods <p>We developed a new, simple approach to estimate HRs by reconstructing life tables from Kaplan–Meier (KM) curves, particularly for small clinical trials. First,&#xa0;we extracted the time points and survival rates from the published&#xa0;KM curves. Then, we reconstructed the life table by reverse derivation of its&#xa0;parameters, using&#xa0;time points and survival rates extracted from the&#xa0;KM curves. Finally,&#xa0;we replotted the KM curves using the Kaplan–Meier method and estimated the HRs via the Cox regression method&#xa0;by SPSS software,&#xa0;using the survival data from the reconstructed life table.</p> Results <p>The estimated HRs of 3 examples were 0.510 (95% CI 0.272–0.958, P = 0.036), 2.472 (95% CI 1.548–3.949, P &lt; 0.001), and 0.591 (95% CI 0.291–1.199, P = 0.145), compared with the original HRs of 0.51 (95% CI 0.27–0.96, P = 0.04), 2.33 (95% CI 1.45–3.73, P &lt; 0.001), and 0.62 (95% CI 0.31–1.26, P = 0.18), respectively.</p> Conclusions <p>This simple approach allows for the estimate of HRs from published KM curves in small survival studies without reported HRs, facilitating their inclusion in meta-analyses. This increases the overall sample size and enhances the reliability of synthesized clinical evidence.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Estimate hazard ratios in small clinical trials without reported hazard ratios

  • Shuyuan Wang,
  • Ziwei Song,
  • Mingjie Wu,
  • Yuanjian Huang

摘要

Background

For survival studies, pooling hazard ratios (HRs) across multiple clinical trials through meta-analysis is commonly performed to achieve widely accepted and robust conclusions. However, clinical trials sometimes do not report HRs.

Methods

We developed a new, simple approach to estimate HRs by reconstructing life tables from Kaplan–Meier (KM) curves, particularly for small clinical trials. First, we extracted the time points and survival rates from the published KM curves. Then, we reconstructed the life table by reverse derivation of its parameters, using time points and survival rates extracted from the KM curves. Finally, we replotted the KM curves using the Kaplan–Meier method and estimated the HRs via the Cox regression method by SPSS software, using the survival data from the reconstructed life table.

Results

The estimated HRs of 3 examples were 0.510 (95% CI 0.272–0.958, P = 0.036), 2.472 (95% CI 1.548–3.949, P < 0.001), and 0.591 (95% CI 0.291–1.199, P = 0.145), compared with the original HRs of 0.51 (95% CI 0.27–0.96, P = 0.04), 2.33 (95% CI 1.45–3.73, P < 0.001), and 0.62 (95% CI 0.31–1.26, P = 0.18), respectively.

Conclusions

This simple approach allows for the estimate of HRs from published KM curves in small survival studies without reported HRs, facilitating their inclusion in meta-analyses. This increases the overall sample size and enhances the reliability of synthesized clinical evidence.